policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
JAVMA news
New listings in AVMA Animal Health Studies Database
Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database.
AVMA news
Advances in animal genome editing continue apace
The Food and Drug Administration (FDA) recently green lit for human consumption five genetically modified pigs at Washington State University.…
JAVMA news
FMD vaccine first allowed to be made in U.S.
A foot-and-mouth disease vaccine conditionally approved in June is the first that can be manufactured on the U.S. mainland because it does not contain…
JAVMA news
Vaccine holds promise for treating osteosarcoma in dogs
Veterinarians in the audience wanted to know when they could get their hands on the new treatment. Dr. Sue Ettinger, a veterinary oncologist, had…
JAVMA news
Veterinarian won Nobel for immunology research
The only veterinarian to win a Nobel Prize, Dr. Peter C. Doherty was a state veterinary officer in Australia before embarking on a career in…
JAVMA news
Academic groups seek easier approval path for gene-edited food animals
Two academic groups argue that the amount of regulatory oversight for genetic changes in food animals should depend on the nature of the changes, and…
JAVMA news
To titer or to revaccinate
It remains confusing and even controversial whether antibody titers are a good measure of immunity when making decisions about
JAVMA news
Racing to save humans through animal research
Veterinary researchers are improving our understanding of the SARS-CoV-2 virus, interspecies transmission, and a host of other public and animal…